Meagan Mulcahy v. HHS - Influenza, Guillain-Barré Syndrome (GBS) (2022)

Filed 2019-10-15Decided 2022-11-29Vaccine Influenza
compensated$83,985

Case summary [AI summaries can sometimes make mistakes]

Meagan Mulcahy filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barré Syndrome (GBS) after receiving an influenza vaccine on October 25, 2016. GBS is a condition listed on the Vaccine Injury Table.

Initially, the respondent opposed compensation, arguing that Ms. Mulcahy had not met the program's severity requirement of suffering residual effects for more than six months.

However, after reviewing additional medical records and literature submitted by Ms. Mulcahy, the respondent conceded that her GBS was a Table injury and that she had established the necessary duration of residual effects.

Consequently, the Chief Special Master issued a ruling on entitlement, finding Ms. Mulcahy entitled to compensation.

A subsequent decision awarded Ms. Mulcahy a total of $83,985.37.

This amount included $80,700.00 for pain and suffering and $3,285.37 for past unreimbursable expenses. The award was made as a lump sum payment to Ms.

Mulcahy, who was determined to be a competent adult.

Source PDFs 3 total · 2 downloaded